<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0019596"><a href="http://purl.obolibrary.org/obo/MONDO_0019596">MONDO:0019596</a></h3>
<p><strong>Label:</strong> 46,XY disorder of sex development due to testicular steroidogenesis defect</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019597">MONDO:0019597</a> (46,XY disorder of sex development due to isolated 17,20-lyase deficiency),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_90796">Orphanet:90796</a>, <a href="http://purl.obolibrary.org/obo/OMIM_202110">OMIM:202110</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0000771">HP:0000771</a> (Gynecomastia) 64.14%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000769">HP:0000769</a> (Abnormality of the breast) and <a href="http://purl.obolibrary.org/obo/HP_0012113">HP:0012113</a> (Abnormality of creatine metabolism) 60.36%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0031093">HP:0031093</a> (Abnormal breast morphology) 57.18%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000769">HP:0000769</a> (Abnormality of the breast) 56.93%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0012113">HP:0012113</a> (Abnormality of creatine metabolism) 53.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system) and <a href="http://purl.obolibrary.org/obo/HP_0012113">HP:0012113</a> (Abnormality of creatine metabolism) 53.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000818">HP:0000818</a> (Abnormality of the endocrine system) and <a href="http://purl.obolibrary.org/obo/HP_0012113">HP:0012113</a> (Abnormality of creatine metabolism) 53.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000707">HP:0000707</a> (Abnormality of the nervous system) and <a href="http://purl.obolibrary.org/obo/HP_0012113">HP:0012113</a> (Abnormality of creatine metabolism) 53.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000119">HP:0000119</a> (Abnormality of the genitourinary system) and <a href="http://purl.obolibrary.org/obo/HP_0012113">HP:0012113</a> (Abnormality of creatine metabolism) 53.87%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000818">HP:0000818</a> (Abnormality of the endocrine system) 53.06%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000119">HP:0000119</a> (Abnormality of the genitourinary system) 52.22%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001939">HP:0001939</a> (Abnormality of metabolism/homeostasis) 52.11%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 51.17%</li>
<li>Thing 51.16%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 51.16%</li>
</ul>
</body>
</html>
